The MESA heart failure risk score: can't we do more?

Heart

Department of National Heart, Lung and Blood Institute's and Boston University's Framingham Heart Study, Framingham, Massachusetts, USA Section of Cardiovascular Medicine, Department of Medicine, Boston University, Boston, Massachusetts, USA.

Published: January 2015

Download full-text PDF

Source
http://dx.doi.org/10.1136/heartjnl-2014-306459DOI Listing

Publication Analysis

Top Keywords

mesa heart
4
heart failure
4
failure risk
4
risk score
4
score more?
4
mesa
1
failure
1
risk
1
score
1
more?
1

Similar Publications

Large-scale gene-environment interaction (GxE) discovery efforts often involve analytical compromises for the sake of data harmonization and statistical power. Refinement of exposures, covariates, outcomes, and population subsets may be helpful to establish often-elusive replication and evaluate potential clinical utility. Here, we used additional datasets, an expanded set of statistical models, and interrogation of lipoprotein metabolism via nuclear magnetic resonance (NMR)-based lipoprotein subfractions to refine a previously discovered GxE modifying the relationship between physical activity (PA) and HDL-cholesterol (HDL-C).

View Article and Find Full Text PDF

Background: There is significant heterogeneity in cardiovascular disease (CVD) risk among patients with diabetes mellitus (DM).

Objectives: The purpose of this study was to develop risk scores for total CVD and its components from a contemporary pooled, observational cohort of U.S.

View Article and Find Full Text PDF
Article Synopsis
  • AI-CAC automated left atrial volumetry offers more actionable insights compared to traditional methods like the Agatston coronary artery calcium score, predicting atrial fibrillation (AF) as early as one year.
  • The study evaluated the effectiveness of AI-CAC against human-measured left atrial volumes using cardiac magnetic resonance imaging (CMRI) in predicting AF and stroke, alongside established risk scores and biomarkers.
  • Results showed that AI-CAC and CMRI provided similar predictive capabilities for AF and stroke over a 15-year period, indicating potential for AI-CAC in clinical settings, but further research is needed to confirm its utility.
View Article and Find Full Text PDF
Article Synopsis
  • Cardiac resynchronization therapy (CRT) is effective for treating heart failure but is under-researched in patients with common comorbidities like atrial fibrillation (AF).
  • The SMART registry enrolled 2035 patients to assess CRT response based on clinical outcomes over 12 months, focusing on factors like all-cause mortality, hospitalizations, and quality of life.
  • Results showed 58.9% of patients improved, but factors like age, AF, and diabetes were linked to lower CRT responsiveness, with patients having AF experiencing higher rates of hospitalizations and mortality compared to those in normal rhythm.
View Article and Find Full Text PDF

Background: To describe the epidemiology and clinical characteristics of migraine and the status of treatment in Colombia. Additionally, the use of health resources by patients was measured.

Methods: This was a non-interventional, retrospective, descriptive study conducted in one Colombian Health Management Organization (HMO) from 2018 to 2022 with a follow-up period of 5 years.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!